News
Filters
Showing 1 - 4 out of 4 results
News
KCTV: Skin Cancer Is the Most Common Type of Cancer. Here's How You Can Help Prevent It.
Skin cancer is the most common cancer in the United States, with an estimated 1 in 5 Americans developing skin cancer in their lifetime. This summer season, Megan McNally, MD, a fellowship-trained surgical oncologist with Saint Luke's Cancer Institute, joined KCTV to share helpful insights on skin safety.
Patient Stories
Fairway Man Becomes First Saint Luke’s Patient to Receive Targeted Radiation Therapy
Dana Boucher found relief with LUTATHERA, a targeted radioactive therapy specifically for neuroendocrine tumors (NETs) found in the gut or pancreas.
News
BBC News: Studies Reveal New Effects of Semaglutide
BBC News talked to Dr. Mikhail Kosiborod about new findings on the cardiovascular effects of semaglutide.
Article
American Journal of Managed Care: Semaglutide Enhances Heart Failure Outcomes in Obesity
A new subanalysis presented by Dr. Mikhail Kosiborod shows benefits of semaglutide in patients with atrial fibrillation.